LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 192 filers reported holding LEGEND BIOTECH CORP in Q2 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $882,426 | -12.7% | 18,300 | -9.7% | 0.65% | -17.2% |
| Q4 2022 | $1,011,279 | +22.0% | 20,258 | -0.3% | 0.79% | +48.3% |
| Q3 2022 | $829,000 | +35.0% | 20,318 | +82.0% | 0.53% | +62.7% |
| Q2 2022 | $614,000 | +124.9% | 11,163 | +48.5% | 0.33% | +181.9% |
| Q1 2022 | $273,000 | -38.4% | 7,516 | -20.8% | 0.12% | +1.8% |
| Q4 2021 | $443,000 | – | 9,495 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 1,629,173 | $89,605,000 | 22.89% |
| Paradigm Biocapital Advisors LP | 978,596 | $53,823,000 | 10.73% |
| FengHe Fund Management Pte. Ltd. | 475,263 | $26,139,000 | 10.25% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,222,342 | $67,229,000 | 9.65% |
| HHLR ADVISORS, LTD. | 4,436,617 | $244,014,000 | 5.23% |
| Iron Triangle Partners LP | 495,329 | $27,243,000 | 3.53% |
| Parkman Healthcare Partners LLC | 117,807 | $6,479,000 | 2.39% |
| AtonRa Partners | 28,172 | $1,549,000 | 1.42% |
| Vivo Capital, LLC | 244,375 | $13,441,000 | 1.35% |
| Avidity Partners Management LP | 1,000,000 | $55,000,000 | 1.26% |